Healthcare
Aurobindo Pharma Limited (AUROPHARMA)
Aurobindo Pharma Limited (AUROPHARMA) is an NSE-listed Healthcare company. latest close ₹1,621.3, 1-day return +0.8%, 1-week return -0.1%. This page shows price, returns, and technical signals from QUANTSCASE. Informational only — not investment advice.
Data as of 20 Aug 2026
For informational and educational purposes only. Not investment advice. QUANTSCASE is a stock screener, not a SEBI-registered investment adviser, research analyst, or portfolio manager. Terms
Price & returns
- Last close
- ₹1,621.3
- 1-day return
- +0.8%
- 1-week return
- -0.1%
- 1-month return
- +5.7%
Technical signals
Latest daily indicators. These are screen readings, not buy or sell calls.
- RSI (14)
- 62.9
- ADX (14)
- 12.2
- ROC 10
- -2.2%
- vs 52W high
- -3.6%
Fundamentals snapshot
Latest fields from our NSE fundamentals table. Figures can lag the live tape.
- Market cap
- ₹93,286 Cr
- P/E
- 25.3
- P/B
- 2.49
- ROE
- —
- D/E
- 21.31
- Net margin
- 10.6%
- Rev. growth YoY
- 8.7%
- Div. yield
- 24.0%
- 52W high
- ₹1,682.4
- 52W low
- ₹1,016.1
- EPS (TTM)
- ₹64.04
Live signals
Built from the latest price, 1-day / 1-week return, and technical snapshot — not a news calendar.
- signal
1-day return +0.8%
Latest 1-day price change versus the previous close.
- signal
1-week return -0.1%
Price change over the last five trading sessions.
- signal
Within 3.6% of the 52-week high
Price is near the 52-week high on the latest technicals snapshot.
News & screener mentions
Recent QUANTSCASE daily posts that listed AUROPHARMA.
No recent screener posts mentioned AUROPHARMA yet. New daily posts will show up here automatically.
